Pular para o conteúdo
Merck
  • Hippo Pathway Activation in Aged Mesenchymal Stem Cells Contributes to the Dysregulation of Hepatic Inflammation in Aged Mice.

Hippo Pathway Activation in Aged Mesenchymal Stem Cells Contributes to the Dysregulation of Hepatic Inflammation in Aged Mice.

Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023-08-07)
Xue Yang, Chen Zong, Chao Feng, Cangang Zhang, Artem Smirnov, Gangqi Sun, Changchun Shao, Luyao Zhang, Xiaojuan Hou, Wenting Liu, Yan Meng, Liying Zhang, Changshun Shao, Lixin Wei, Gerry Melino, Yufang Shi
RESUMO

Aging is always accompanied by chronic diseases which probably attribute to long-term chronic inflammation in the aging body. Whereas, the mechanism of chronic inflammation in aging body is still obscure. Mesenchymal stem cells (MSCs) are capable of local chemotaxis to sites of inflammation and play a powerful role in immune regulation. Whether degeneration of MSCs in the aging body is associated with unbalanced inflammation is still not clear. In this study, immunosuppressive properties of aged MSCs are found to be repressed. The impaired immunosuppressive function of aged MSCs is associated with lower expression of the Hippo effector Yes-associated protein 1 (YAP1) and its target gene signal transducer and activator of transcription 1 (STAT1). YAP1 regulates the transcription of STAT1 through binding with its promoter. In conclusion, a novel YAP1/STAT1 axis maintaining immunosuppressive function of MSCs is revealed and impairment of this signal pathway in aged MSCs probably resulted in higher inflammation in aged mice liver.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
Anti-LATS1 (N-term) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution